Corebridge Financial’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-19,094	Closed	-$220K	–	1420
2025 Q1	$220K	Buy	19,094 +2,149	+13%	+$24.8K	﹤0.01%	2021
2024 Q4	$144K	Sell	16,945 -3,682	-18%	-$31.2K	﹤0.01%	2359
2024 Q3	$239K	Buy	20,627 +138	+0.7%	+$1.6K	﹤0.01%	2129
2024 Q2	$241K	Buy	+20,489	New	+$241K	﹤0.01%	2080